Microalbuminuria: A Marker to Increased Renal and Cardiovascular Risk in Diabetes Mellitus

Mogensen CE . Systemic blood pressure and glomerular leakage with particular reference to diabetes and hypertension. J Intern Med;, 1994; 235, 297–316.

Parving HH Andersen AR Smidt UM Hommel E Mathiesen ER Svendsen PA . Effect of antihypertensive therapy on kidney function in diabetic nephropathy. Br Med J, 1987; 294, 1443–47.

Parving HH Oxenbell B Svendson PA Christiansen JS Anderson AR . Early detection of patients at risk of developing diabetic nephropathy. Acta Endocrinol, 1982; 100, 550–55.

Viberti GC Hill RD Jarrett RJ Argyropoulos A Mahmad U Keen H , Microalbuminuria as a predictor of clinical nephropathy in insulin dependent diabetes mellitus. Lancet 1982; 1, 1430–32.

Mogensen CE Christensen CK . Predicting diabetic nephropathy in insulin dependent patients. N Engl J Med, 1984; 311, 89–93.

Rossing P Hougaard P Borch-Johnsen K Parving HH . Predictors of mortality in insulin dependent diabetes: 10 year observational study. Br Med J, 1996; 313, 779–84.

Mogensen CE . Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes mellitus. N Engl J Med, 1984; 310, 356–60.

Jarrett RJ Viberti GC Argyropoulos A Hill RD Mahmad U Murrells TJ . Microalbuminuria predicts early mortality in insulin dependent diabetes mellitus. Diab Med, 1984; 1, 17–19.

Mogensen CE Vittinghus E . Urinary albumin excretion during exercise in juvenile diabetes. Scand J Lab Invest, 1975; 35, 295–300.

Hutchinson ASO Reilly DSTJ MacCuish A . Albumin excretion rate, albumin concentration, and albumin/creatinine ratio compared for screening diabetics for slight albuminuria. Clin Chem, 1988:34, 2019–21.

Cowell CT Rogers S Silink M . First morning urinary albumin concentration is a good predictor of 24 hour urinary albumin excretion in children with Type 1(insulin dependent) diabetes. Diabetologia, 1986; 29, 97–99.

Mogensen CE Chachati A. Christensen CK Deckert T Hommel E Microalbuminuria, an early marker of renal involvement in diabetes. Uraemia investigation 1986; 9:85–95.

Chase HP Marshall G Garg SK Harris S Osberg I . Borderline increases in albumin excretion rate and the relation to glycaemic control in subjects with type 1 diabetes mellitus. Clin Chem, 1991; 37, 2048–52.

MacLeod JM Lutale J Marshall SM . Albumin excretion and vascular deaths in NIDDM. Diabetologia, 1995; 38, 610–16.

Cohen DL Close CF Viberti GC . The variability of overnight albumin excretion in IDDM and normal subjects. Diab Med, 1987; 4, 437–40.

Feldt-Rasmussen B Mathiesen E . Variability of urinary albumin excretion in incipient diabetic nephropathy. Diabet Nephropathy, 1984; 3, 101–103.

Chalmers J Thompson CJ McBain A . Regression of microalbuminuria in IDDM. Diab Med, 1995; 12(Suppl 1): P 104.

Microalbuminuria Collaborative Study Group UK. Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. Br Med J 1995; 311, 973–77.

The Diabetic Control and Complications (DCCT) Research Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 1995; 47, 1703–20.

Feldt-Rasmussen B . Increased transcapillary escape of albumin in type 1 diabetic patients with microalbuminuria. Diabetologia, 1986; 29, 282–86.

Bangstad HJ Osterby R Dahl-Jorgensen K Berg KJ Hartmann A Nyberg G . Early glomerulopathy is present in young type 1 diabetic patients with microalbuminuria. Diabetologia, 1993; 36, 523–29.

Schmitz A . Renal function changes in middle aged and elderly type 2 diabetic patients. Diabetologia, 1993; 36, 985–92.

Jaffa AA Rust PF Mayfield RK . Kinin, a mediator of diabetes induced glomerular hyperfiltration. Diabetes, 1995; 44, 156–60.

Perico N Benigni A Gabanelli M Piccinelli A Rog M De Riva C Remuzzi G . Atrial natriuretic peptide and prostacyclin synergistically mediate hyperfiltration and hyperperfusion in diabetic rats. Diabetes, 1992; 41, 533–38.

Bank N Aynedijan HS . Role of EDRF(nitric oxide) in diabetic renal hyperfiltration. Kidney Int, 1993; 43, 1306–12.

Deckert T Feldt-Rasmussen B Borch-Johnsen Jensen T Enevoldsen Kofoed A . Albuminuria reflects widespread vascular damage: The Steno hypothesis. Diabetologia, 1989; 32, 219–26.

Tamsma JT Van der Born J Assman KJM Weening JI Berden JHM . Expression of glomerular extracellular matrix components in human diabetic nephropathy; decrease of heparan sulphate in the glomerular basement membrane. Diabetologia, 1994; 37, 313–20.

Bell GM Bernstein RK Laragh JH Atlas SA James GD Pecker MS Sealey JE . Increased plasma atrial natriuretic factor and reduced plasma renin in patients with poorly controlled diabetes mellitus. Clin Sci, 1989; 77, 177–82.

Hirata Y Suzukl Y Hayakawa H Suzuki E Kimura K Goto A Kangawa K Matsuo H Omata M . Participation of endogenous atrial natriuretic peptide in the regulation of urinary protein excretion in experimental diabetic rats. Clin Sci, 1995; 88, 413–19.

Thompson CJ Prasad N Clarkson PBM Struthers AD . Atrial natriuretic peptide increases urinary albumin excretion in insulin dependent diabetes humans with microalbuminuria. Diab Med, 1995; 12(Suppl 2):A31.

Shankland SJ Scholey JW . Expression of transforming growth factor during diabetic renal hypertrophy. Kidney Int, 1994; 46: 43042.

Kagami S Border WA Miller DE Noble NA . Angiotensin 11 stimulates extracellular matrix protein synthesis through induction of transforming growth factor B expression in rat glomerular mesangial cells. J Clin Invest, 1994; 93, 2431–37.

Yokoyama H Deckert T . Central role of TGF B in the pathogenesis of diabetic nephropathy and macrovascular complications: A Hypothesis. Diab Med, 1996; 13, 312–20.

Marre M Passa P . Prevalence of microalbuminuria in the diabetic clinic. In: Mogensen CE , ed. The Kidney and Hypertension in diabetes. Boston: Martinus Nijhoff Publishing 1988, 51–58.

Andersen AR Christiansen JS Andersen JK Kreiner S Deckert T . Diabetic nephropathy in Type 1(insulin dependent) diabetes. An epidemiological study. Diabetologia, 1983; 25, 496–501.

Kofoed-Enevoldsen A Borch-Johnsen K Kreiner S Nerup J Deckert T . Declining incidence of persistent proteinuria in Type 1(insulin dependent) diabetic patients in Denmark. Diabetes, 1987; 36, 205–209.

Microalbuminuria Collaborative Study Group. Risk factors for development of microalbuminuria in insulin dependent diabetic patients: A cohort study. Br Med J 1993; 306, 1235–39.

Allawi J Rao PV Gilbert R Scott G Jarrett RJ Keen H . Microalbuminuria in non insulin dependent diabetes: Its prevalence in Indian compared with Europid patients. Br Med J, 1988; 296, 462–64.

Samanta A Burden AC Feehally J Walls J . Diabetic renal disease: Differences between Asian and white Caucasians. Br Med J, 1986; 293, 366–67.

Rossing R Tarnow L Nielsen FS Boelskifte S Brenner BM Parving HH . Short stature and diabetic nephropathy. Br Med J, 1995:310;296–97.

Forsblom CM Groop P-H Ekstrand A Groop LC . Predictive value of microalbuminuria in insulin dependent diabetes of long duration. Br Med J, 1992; 305, 1051–1053.

Mathiesen ER Ronn B Storm B Foght H Deckert T . The natural course of microaibuminuria in insulin dependent diabetes: A 10 year prospective study. Diab Med, 1995; 12, 482–87.

Feldt-Rasmussen B Mathiesen ER Jensen T Deckert T . Effects of improved metabolic control on loss of kidney function in Type 1 (insulin dependent diabetic) patients; an update of the Steno series. Diabetologia, 1991; 34, 164–70.

Gilbert RE Tsalamandris C Bach LA Panaglo-Topoulis S O'Brien RC Allen TJ . Longterm glycaemic control and the rate of progression of early diabetic kidney disease. Kidney Int, 1993;j44:855–859.

Reichard P Nilsson BY . The effect of longterm intensified insulin treatment on the development of microvascular of diabetes mellitus. N Engl J Med, 1993; 329, 304–309.

Christensen CK Mogensen CE . The course of incipient nephropathy: Studies on albumin excretion and blood pressure. Diab Med, 1985, 2, 97–102.

Hansen KW Pederson Mau M Marshall SM Christiansen JS Mogensen CE . Circadian variation of blood pressure in patients with diabetic nephropathy. Diabetologia, 1992; 35, 1074–79.

Melbourne Diabetic Nephropathy Study Group. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Br Med J 1991; 302, 210–16.

Chan JCN Cockram CS Nicholls MG Cheung CK Swaminatan R . Comparison of enalapril and nifedipine in treating non insulin dependent diabetes associated with hypertension; one year analysis. Br Med J, 1992; 305, 981–85.

O'Donnell MJ Rowe BR Lawson N Horton A Gyde H Barnett AH . Comparison of the effects of angiotensin converting enzyme inhibitor and a calcium channel antagonist in hypertensive, macroproteinuric diabetic patients. J Human Hyperten, 1993; 7: 33339.

Weidmann P Boehlen LM de Courten M Ferrari P . Antihypertensive therapy in diabetic patients. J Hum Hypert, 1992; 6(Suppl 2):s23–36.

Demarie BK Bakris GL . Effects of different classes of calcium antagonists on proteinuria in diabetic subiects. Ann Int Med, 1990; 113, 987–88.

Lewis EJ Hunsicker LG Bain RP , Rohde RD for the collaborative study group. The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. N Engl J Med, 1993; 329: 14561562.

Rudberg S Aperia A Freyschuss U Persson B . Enalapril reduces microalbuminuria in young normotensive Type 1 (insulin dependent diabetic patients irrespective of its hypotensive effect. Diabetologia, 1990; 33, 470–76.

Mogensen CE Hansen KW Pedersen MM Christensen CK . Renal factors influencing blood pressure threshold and choice of treatment for hypertension in IDDM. Diabetes Care, 1991; 14(suppl 13–26.).

Rossing P Hommel E Smidt UM Parving HH . Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes, 1993; 42, 715–19.

Bakris G Slataper R Vicknair N Sadler R . ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive diabetic subjects. J Diab Comp, 1994; 8, 2–6.

Marre M Chatellier G LeBlanc H Suarez L Guyenne TT Menard J Passa P . Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. Br Med J, 1988; 297: 1092.

Gall MA Borch-Johnsen K Hougaard P Nielsen FS Parving HH . Albuminuria and poor glycaemic control predict mortality in NIDDM. Diabetes, 1995; 44, 1303–1309.

North American Microalbuminuria Study Group. The beneficial effect of angiotensin converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. Am J Med 1995; 99, 497–504.

Viberti G Mogensen CE Leif C Groop MD , Pauls JF for the European microalbuminuria captopril study group. Effect of captopril on progression to clinical proteinuria in patients with insulin dependent diabetes mellitus and microalbuminuria. JAMA, 1994; 271, 275–79.

Cohen D Dodds R Viberti G . Effect of protein restriction in insulin dependent diabetics at risk of nephropathy. Br Med J, 1987; 294, 795–98.

Dullaart RPF Dikleschei LD . Alterations of serum lipids and apolipoproteins in male Type 1 patients with microalbuminuria. Diabetologia, 1989; 32, 685–89.

Ceriello A . Coaqulation activation in diabetes mellitus: The role of hyperglycaemia and therapeutic prospects. Diabetologia, 1993; 36, 1119–25.

Myrup B Rossing P Jensen T Gram J Kluft C Jespersen J . Procoagulant activity and intimal dysfunction in IDDM. Diabetologia, 1995; 38, 73–78.

Dean JD Durrington PN . Treatment of dyslipoproteinaemia in diabetes mellitus. Diab Med, 1996; 13, 297–312.

Yudkin JS . How can we best prolong life? Benefits of coronary risk factor reduction in non diabetic and diabetic subjects. Br Med J, 1993; 306, 1313–18.

Parving HH Hommel E Mathiesen E Skott P Edsberg B Bahnser M . Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J, 1988; 296, 156–60.

Cruickshanks AJ Ritter LL Klein R Moss SE . The association of microalbuminuria with diabetic retinopathy. The Wisconsin Epidemiologic study of diabetic retinopathy. Ophthalmology, 1993; 100, 862–67.

Winocour PH . Microalbuminuria; worth screening for in early morning urine samples in diabetic, hypertensive and elderly patients. BMJ, 1992; 304, 1196–97.

Collins VR Dowse GK Finch CF Zimmet PZ Linnane AW . Prevalence and risk factors for micro and macroalbuminuria in diabetic subjects and entire population of Nauru. Diabetes, 1989; 38, 1602–09.

United Kingdom Prospective Diabetes Study. Prevalence of hypertension and hypotensive therapy in patients with newly diagnosed diabetes. A multicentre study. Hypertension 1985; 7(Suppl 11):8–13.

Mogensen CE . Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med, 1994; 6, 356–60.

Nielsen S Schmitz A Rehling M Mogensen CE . Systolic blood pressure relates to the rate of decline of glomerular filtration rate in Type 2 diabetes mellitus. Diabetes Care, 1993; 16, 1427–32.

Schmitz A Vaeth M . Microalbuminuria; a major cardiovascular risk factor in non insulin dependent diabetes mellitus. A 10 year follow up study of 503 patients. Diab Med, 1990; 7, 115–18.

Neil A Hawkins M Putok M Thorogood M Cohen D Mann J . A prospective population based study of microalbuminuria as predictor of mortality in NIDDM. Diabetes care, 1993; 16, 996–1003.

Mattock MB Morrish MJ Viberti G Keen H Fitzgerald AP Jackson G . Prospective study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes, 1992; 41, 736–42.

Romero R Salinas I Lucas A Abad E Reverter J Johnston S Lucas A Sanmarti A Abad E . Renal function changes in microalbuminuric normotensive Type 11 diabetic patients treated with angiotensin converting enzyme inhibitors. Diabetes Care, 1993; 16, 597–600.

Sano T Kawamura T Matsummae H Sasaki H Nakayama M Hara T Matsuo S Hotta N Sakamoto N . Effects of longterm enalapril treatment on persistent microalbuminuria in well controlled hyper-tensive and normotensive NIDDM patients. Diabetes Care, 1994; 17, 420–24.

Ravid M Savin H Jutrin I Bental T Katz B Lishner M . Longterm stabilising effect of angiotensin converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive Type 11 diabetic patients. Ann Int Med, 1993; 118, 577–81.

Nielsen FS Rossing P Gall MA Skott P Smidt M Parving HH . Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM patients with diabetic nephropathy. Diabetes, 1994; 43, 1108–13.

Christensen CK Mogensen CE . Antihypertensive treatment; longterm reversal of progression of albuminuria in incipient nephropathy: A longitudinal study of renal function. J Diab Comp, 1987; 1, 45–52.

Mattock MB Keen H Viberti CG Eigohari MR Murells TJ Cott GS . Coronary heart disease and urinary albumin excretion rate in Type 11(non insulin dependent) diabetic patients. Diabetoloaia, 1988; 31, 82–7.

Chan P Pan WH . Coagulation activation in Type 11 diabetes mellitus: The higher coronary risk profile of female diabetic patients. Diab Med, 1995; 12, 504–507.

Siegel JE Krolewski AS Warram JH Weinstein MC . Cost effectiveness of screening and early treatment of nephropathy in patients with insulin dependent diabetes mellitus. J Am Soc Nephrol, 1992; 3(Suppl 4):slll–119.

Seaquist ER Goetz FC Rich S Barbosa J . Familial clustering of diabetic renal disease. Evidence of genetic susceptibility to diabetic nephropathy. N Engl J Med, 1989; 320, 1161–1165.

Borch-Johnsen K Norgaard K Hommel E Mathiesen ER Jensen JS Deckert T . Kidney Int 1992; 41, 719–22.

Shepherd J Cobbe SM Ford I . Prevention of coronary heart disease with pravistatin in men with hypercholesterolaemia N Engl J Med 1995; 333, 1301–07.